Comparative Analysis of Cervical Cerclage and Arabin Pessary in Preventing Preterm Births in Singleton Pregnancies with Cervical Insufficiency
European Journal of Clinical Pharmacy · 26.12.2025 · 7 (1) · 6298-6303
DOI: 10.61336/ejcp/26-01-286 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 26.12.2025.
Abstract (Originalsprache)
Introduction
Preterm birth prevention attempts have been focused on treating symptoms or markers of activation of the common pathway of parturition, such as membrane decidual activation, preterm cervical ripening, and/or enhanced uterine contractility. In women at risk, progesterone, cervical cerclage, and cervical pessary have all been shown in individual meta-analyses to be beneficial in reducing PTB when compared to a placebo or standard care. Study design: Descriptive, case series study. Settings: Department of Obstetrics & Gynaecology, Fatima Memorial Hospital, Lahore. Study duration: May 11, 2025 to October 10, 2025. Materials & Methods: The study comprised 130 women aged 18 to 40 who had singleton pregnancies lasting 18 to 24 weeks and cervical length of < 25 mm, with or without funnelling. Exclusion criteria included uterine abnormalities, recurrent miscarriages, dilated cervix and/or protruding amnio-chorial membranes, rupture of the membranes at the time of admission. The number of patients who received Arabin® pessary and cervical cerclage was recorded. Patients who received the Arabin® pessary were in Group A, and patients who had cervical cerclage surgery were in Group B. Additionally, from week 16 to week 36 of pregnancy, all individuals received 200 mg/day of vaginal progesterone. On a specially created proforma, the researcher herself recorded low birth weight and preterm birth (live birth < 37 weeks of gestation).
Results
Of the participants in this study, 41 (31.54%) had the Arabin® pessary insertion and 89 (68.86%) had the cervical cerclage surgery. With a statistically significant difference (p = 0.0036), the frequency of premature deliveries was determined to be 21.35% in the cervical cerclage group and 46.34% in the Arabin pessary group. Without a statistically significant difference, the rates of low birth weight and cesarean delivery were 13.48% and 24.72% in the cervical cerclage group and 7.32% and 26.83% in the Arabin pessary group.
Conclusion
In comparison to arabin pessary, this study found that cervical cerclage is more effective at preventing premature births in singleton pregnancies with cervical insufficiency
Zitieren
APA
(2025). Comparative Analysis of Cervical Cerclage and Arabin Pessary in Preventing Preterm Births in Singleton Pregnancies with Cervical Insufficiency. European Journal of Clinical Pharmacy, 7(1), 6298-6303. https://doi.org/10.61336/ejcp/26-01-286
Vancouver
Comparative Analysis of Cervical Cerclage and Arabin Pessary in Preventing Preterm Births in Singleton Pregnancies with Cervical Insufficiency. European Journal of Clinical Pharmacy. 2025;7(1):6298-6303. doi:10.61336/ejcp/26-01-286
BibTeX
@article{euvimed2025,
title = {Comparative Analysis of Cervical Cerclage and Arabin Pessary in Preventing Preterm Births in Singleton Pregnancies with Cervical Insufficiency},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {6298--6303},
doi = {10.61336/ejcp/26-01-286}
}
EUVIMED